EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

An ageing biomarker signature predicts chronic disease cluster trajectories, physical function and mortality: validation in the TILDA and HRS cohorts

Belinda Hernández, Eric Klopack, Frank Moriarty iD, Padraic Fallon, Nollaig Bourke, Eileen Crimmins, Rose-Anne Kenny, Cathal Mc Crory, Aisling O'Halloran iD

Age and Ageing · 04.05.2026 · 55 (5)

DOI: 10.1093/ageing/afag135 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Age and Ageing, online erschienen am 20.05.2026. Verfasst von Belinda Hernández und 8 weiteren Autor:innen. Beteiligte Einrichtung: The National Center for Pharmacoeconomics (NCPE), St James's Hospital, Dublin, DO8 XN61, Ireland. Hauptthemen laut MEDLINE: Aging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Board, Atlantic Philanthropies, Irish Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Global population ageing is progressing at an unprecedented rate. Early identification of subpopulations at risk of chronic diseases could mitigate deteriorating health and increasing health service use, while revealing key biological cues and therapeutic targets. We hypothesised that a multisystem biomarker signature could identify future chronic disease trajectories, multimorbidity, functional decline and mortality.

Methods

Eighteen blood biomarkers, representing key systems that become dysregulated with ageing, were assessed among n = 4961 participants aged 50+ years from Ireland. Probabilistic clustering classified participants as belonging to one of three biomarker signatures at baseline. Biomarker signatures were designated as low, medium and high risk based on relative levels of biomarker dysregulation within the signatures and previously described associations with chronic disease and mortality. These biomarker signatures were utilised to predict 4-year functional decline; 8-year cardiovascular disease (CVD), diabetes, frailty, disability and 12-year mortality. Results were validated in a US cohort (n = 3914).

Results

Low (58.5%), medium (9.2%) and high-risk (32.3%) biomarker signatures were identified in the cohort from Ireland. The high-risk signature was associated with higher 12-year mortality (HR: 1.89, P < .001); higher 8-year incidence of CVD, diabetes, multimorbidity, frailty and disability (OR range: 1.46–2.49. P < .05); and lower 4-year physical function (P < .01). Findings were corroborated in the US cohort. We identified and tracked 6 disease classes over 8 years: healthy, arthritis, diabetes/angina, hypothyroid/osteoporosis/respiratory, vision/anxiety/CVD and multisystem. Associations between the high-risk biomarker signature and two of the five 8-year incident disease classes were observed, implicating dysregulated immune and cardiometabolic pathways.

Conclusions

This study provides evidence that biomarker signatures and profiling of disease patterns can be used to risk stratify and identify ageing subpopulations that would benefit most from targeted preventative or secondary intervention strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingHumansBiomarkersFemaleChronic DiseaseIrelandMaleRisk FactorsMiddle AgedAgedPredictive Value of TestsRisk AssessmentMultimorbidityAge FactorsCardiovascular DiseasesReproducibility of ResultsFunctional StatusFrailtyUnited StatesCluster AnalysisTime Factors

Stichwörter der Autor:innen

ageing biomarker signaturedisease clustersmultimorbidity trajectoriesolder people

Substanzen

Biomarkers

Autor:innen und Institutionen

  • The National Center for Pharmacoeconomics (NCPE), St James's Hospital, Dublin, DO8 XN61, Ireland.
  • The Irish Longitudinal Study on Ageing (TILDA), Trinity College Dublin, Dublin, D02 R590, Ireland.
  • Davis School of Gerontology, University of Southern California, Los Angeles, CA 90089, USA.
  • HRB Centre for Primary Care Research, RCSI University of Medicine and Health Sciences, Dublin, D02 YN77, Ireland.
  • Trinity College Dublin, Dublin D02 PN40, Leinster, Ireland.
  • University of Southern California, Los Angeles, CA 90089, USA.

ORCID-Profile: Frank Moriarty, Aisling O'Halloran

Förderung

  • Health Research Board
  • Atlantic Philanthropies
  • Irish Government

Zitieren

APA

Hernández, B., Klopack, E., Moriarty, F., Fallon, P., Bourke, N., Crimmins, E., Kenny, R. A., Crory, C. M., & O'Halloran, A. (2026). An ageing biomarker signature predicts chronic disease cluster trajectories, physical function and mortality: validation in the TILDA and HRS cohorts. Age and Ageing, 55(5). https://doi.org/10.1093/ageing/afag135

Vancouver

Hernández B, Klopack E, Moriarty F, Fallon P, Bourke N, Crimmins E, et al. An ageing biomarker signature predicts chronic disease cluster trajectories, physical function and mortality: validation in the TILDA and HRS cohorts. Age and Ageing. 2026;55(5). doi:10.1093/ageing/afag135

BibTeX
@article{Hernndez2026,
  author = {Hernández, Belinda and Klopack, Eric and Moriarty, Frank and Fallon, Padraic and Bourke, Nollaig and Crimmins, Eileen and Kenny, Rose-Anne and Crory, Cathal Mc and O'Halloran, Aisling},
  title = {An ageing biomarker signature predicts chronic disease cluster trajectories, physical function and mortality: validation in the TILDA and HRS cohorts},
  journal = {Age and Ageing},
  year = {2026},
  volume = {55},
  number = {5},
  doi = {10.1093/ageing/afag135}
}
Kostenlos starten →